discontinued

AR10592PU-S Hepatitis C Virus NS3 subtype 1c

Search for all "Hepatitis C Virus NS3 subtype 1c"

Vue générale rapide

Hepatitis C Virus NS3 subtype 1c

AR10592PU-S

Description du Produit Hepatitis C Virus NS3 subtype 1c

Hepatitis C Virus NS3 subtype 1c.
Presentation: Purified

Caractéristiques du Produit Hepatitis C Virus NS3 subtype 1c

Type de Produit Proteins & Growth Factors
Quantité 0.1 mg
Presentation Purified
Source E. coli
Destination Worldwide
Fiche Technique Télécharger la fiche technique
Fournisseur OriGene Technologies GmbH
Material Safety DataSheet (MSDS) MSDS for Proteins (de)

Extrait de la Fiche Technique

Pureté >95% pure as determined by 10% PAGE (coomassie staining). 
Purification Method: Sepharose-Derived Purification.
Applications Antigen in ELISA and Western blots, excellent antigen for detection of HCV with minimal specificity problems.
Sujet HCV is a small 50nm, enveloped, single-stranded, positive sense RNAvirus in the family Flaviviridae.
HCV has a high rate of replication with approximately one trillion particles produced each day in an infected individual. Due to lack of proofreading by the HCV RNA polymerase, the HCV has an exceptionally high mutation rate, a factor that may help it elude the host's immune response. Hepatitis C virus is classified into six genotypes(1-6) with several subtypes within each genotype. The preponderance and distribution of HCV genotypes varies globally. Genotype is clinically important in determining potential response to interferon-based therapy and the required duration of such therapy. Genotypes 1 and 4 are less responsive to interferon-based treatment than are the other genotypes (2, 3, 5 and 6). 
Concentration 1.0 mg/ml
Stockage

Store undiluted at 2-8°C for one month or (in aliquots) at -20°C for longer.
Avoid repeated freezing and thawing.
Shelf life: one year from despatch.

Description
Description:
E.coli derived recombinant. The protein contains the full-length HCV NS3 (c33c) immunodominant region.
Specificity: Immunoreactive with sera of HCV-infected individuals, including sera with antibodies to NS3 secondary domains.
Presentation
Buffer:
25mM Tris-HCl, 1mM EDTA, 1.5M Urea, 50% Glycerol
Pureté:
>95% pure as determined by 10% PAGE (coomassie staining). 
Purification Method: Sepharose-Derived Purification.
Format:
Purified
  • LinkedIn